PCSK9 Inhibitor Price Reductions and Medicare Part D Utilization and Spending.

Doshi, Jalpa A, Matthew J Klebanoff, Maya Merchant, Pengxiang Li, and Dhruv S Kazi. 2026. “PCSK9 Inhibitor Price Reductions and Medicare Part D Utilization and Spending.”. JAMA Cardiology.